BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37390225)

  • 1. Invasive Aspergillosis among Haematological Malignancy Patients in Ghana: A Pilot Study on Prevalence and Antifungal Prophylaxis at the National Referral Hospital.
    Ocansey BK; Otoo B; Gbadamosi H; Opintan JA; Dei-Adomakoh Y; Kosmidis C; Denning DW
    West Afr J Med; 2023 Jun; 40(6):613-618. PubMed ID: 37390225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Efficacy of Aspergillus Galactomannan Lateral Flow Assay in Patients with Hematological Malignancies: A Prospective Multicenter Study.
    Alhan O; Saba R; Akalin EH; Ener B; Ture Yuce Z; Deveci B; Guncu MM; Kahveci HN; Yilmaz AF; Odabasi Z
    Mycopathologia; 2023 Oct; 188(5):643-653. PubMed ID: 37273172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Utility of Galactomannan Enzyme Immunoassay in Invasive Aspergillosis in Pediatric patients with Hematological Malignancy.
    Das S; Capoor MR; Singh A; Agarwal Y
    Mycopathologia; 2023 Dec; 188(6):1055-1063. PubMed ID: 37806994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on invasive aspergillosis using galactomannan enzyme immunoassay and determining antifungal drug susceptibility among hospitalized patients with hematologic malignancies or candidates for organ transplantation.
    Ardi P; Daie-Ghazvini R; Hashemi SJ; Salehi MR; Bakhshi H; Rafat Z; Zareei M; Getso M; Basiri S; Sarwestani HK; Boroujeini ZB; Ahmadikia K
    Microb Pathog; 2020 Oct; 147():104382. PubMed ID: 32663605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of posaconazole antifungal prophylaxis in reducing the incidence of invasive aspergillosis in patients with acute myeloid leukemia.
    Le Clech L; Uguen M; Quinio D; Nevez G; Couturier MA; Ianotto JC; Berthou C; Guillerm G; Le Bars H; Payan C; Narbonne V; Baron R; Saliou P
    Curr Res Transl Med; 2020 Jan; 68(1):23-28. PubMed ID: 31787568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of Invasive Aspergillosis in patients with haematological malignancy: A meta-analysis and systematic review.
    van de Peppel RJ; Visser LG; Dekkers OM; de Boer MGJ
    J Infect; 2018 Jun; 76(6):550-562. PubMed ID: 29727605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of clinical characteristics on the performance of galactomannan and PCR for the diagnosis of invasive aspergillosis in febrile neutropenic patients.
    Oz Y; Aslan M; Aksit F; Metintas S; Gunduz E
    Mycoses; 2016 Feb; 59(2):86-92. PubMed ID: 26627843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The misleading effect of serum galactomannan testing in high-risk haematology patients receiving prophylaxis with micafungin.
    Vena A; Bouza E; Álvarez-Uría A; Gayoso J; Martín-Rabadán P; Cajuste F; Guinea J; Gómez Castellá J; Alonso R; Munoz P
    Clin Microbiol Infect; 2017 Dec; 23(12):1000.e1-1000.e4. PubMed ID: 28506782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining standard clinical methods with PCR showed improved diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies and prolonged neutropenia.
    Paholcsek M; Fidler G; Konya J; Rejto L; Mehes G; Bukta E; Loeffler J; Biro S
    BMC Infect Dis; 2015 Jul; 15():251. PubMed ID: 26126706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies.
    Ulusakarya A; Chachaty E; Vantelon JM; Youssef A; Tancrède C; Pico JL; Bourhis JH; Fenaux P; Munck JN
    Hematol J; 2000; 1(2):111-6. PubMed ID: 11920178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion.
    Nosari A; Oreste P; Cairoli R; Montillo M; Carrafiello G; Astolfi A; Muti G; Marbello L; Tedeschi A; Magliano E; Morra E
    Am J Hematol; 2001 Dec; 68(4):231-6. PubMed ID: 11754411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis.
    Cordonnier C; Botterel F; Ben Amor R; Pautas C; Maury S; Kuentz M; Hicheri Y; Bastuji-Garin S; Bretagne S
    Clin Microbiol Infect; 2009 Jan; 15(1):81-6. PubMed ID: 19154482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prospective Multicenter Cohort Surveillance Study of Invasive Aspergillosis in Patients with Hematologic Malignancies in Greece: Impact of the Revised EORTC/MSGERC 2020 Criteria.
    Siopi M; Karakatsanis S; Roumpakis C; Korantanis K; Sambatakou H; Sipsas NV; Tsirigotis P; Pagoni M; Meletiadis J
    J Fungi (Basel); 2021 Jan; 7(1):. PubMed ID: 33466525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patients.
    Couchepin J; Brunel AS; Jaton K; Meylan P; Bochud PY; Lamoth F
    Mycoses; 2018 Jun; 61(6):350-354. PubMed ID: 29453853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009.
    Racil Z; Weinbergerova B; Kocmanova I; Muzik J; Kouba M; Drgona L; Masarova L; Guman T; Tothova E; Forsterova K; Haber J; Ziakova B; Bojtarova E; Vydra J; Mudry P; Foralova R; Sejnova D; Mallatova N; Kandrnal V; Cetkovsky P; Mayer J
    Int J Infect Dis; 2013 Feb; 17(2):e101-9. PubMed ID: 23084969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Aspergillus galactomannan lateral flow assay for the diagnosis of invasive aspergillosis: A single-centre study.
    Serin I; Dogu MH
    Mycoses; 2021 Jun; 64(6):678-683. PubMed ID: 33683715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies.
    Rogers TR; Morton CO; Springer J; Conneally E; Heinz W; Kenny C; Frost S; Einsele H; Loeffler J
    Br J Haematol; 2013 May; 161(4):517-24. PubMed ID: 23614624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Evaluation of the Performance of the IMMY
    White PL; Price JS; Posso R; Vale L; Backx M
    J Clin Microbiol; 2020 Nov; 58(12):. PubMed ID: 32967903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Commercially Available Real-Time Polymerase Chain Reaction Assays for the Diagnosis of Invasive Aspergillosis in Patients with Haematological Malignancies.
    Erman-Daloglu A; Ozhak B; Salim O; Turhan O; Ongut G; Gunseren F; Colak D; Ogunc D
    Mycopathologia; 2020 Apr; 185(2):269-277. PubMed ID: 31950340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
    Pazos C; Pontón J; Del Palacio A
    J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.